caffeine has been researched along with regadenoson in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| de Lera Ruiz, M; Lim, YH; Zheng, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Belardinelli, L; Hintze, TH; Leung, K; Messina, E; Ochoa, M; Shryock, J; Sun, HL; Xu, X; Zhao, G | 1 |
| Fleischman, S; Gaemperli, O; Kaufmann, PA; Koepfli, P; Lieu, H; Nguyen, P; Olmsted, A; Schepis, T; Siegrist, PT; Wang, W | 1 |
| Abbott, BG; Gemignani, AS | 1 |
| Franks, B; Iskandrian, AE; McNutt, BE; Tejani, FH; Thompson, RC | 1 |
| Bukofzer, S; Kristy, R; Tejani, FH; Thompson, RC | 1 |
| Bitar, A; Kreutz, RP; Mastouri, R | 1 |
| Doran, JA; Gupta, R; Mackin, ML; Sajjad, W; Schneider, MD; Schwartz, RG | 1 |
| Jolly, AF; Thomas, GS | 1 |
| Kaandorp, TAM; Kuijpers, D; Oudkerk, M; van der Harst, P; van Dijk, R; van Dijkman, PRM; Vliegenthart, R | 1 |
| Babar, AK; Bui, L; DeGolovine, A; Gould, KL; Johnson, NP; Kitkungvan, D; Kumar, S; Madjid, M; Nacimbene, A; Patel, MB; Roby, AE; Vejpongsa, P | 1 |
| Abidov, A; Harhash, AA; Huang, JJ; Kay, MD; Krupinski, EA; Kuo, PH; McMillan, NA; Posch, MI | 1 |
3 review(s) available for caffeine and regadenoson
| Article | Year |
|---|---|
Adenosine A2A receptor as a drug discovery target.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction | 2014 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The emerging role of the selective A2A agonist in pharmacologic stress testing.
Topics: Animals; Caffeine; Exercise; Humans; Myocardial Perfusion Imaging; Purines; Pyrazoles; Receptor, Adenosine A2A; Vasodilation | 2010 |
5 trial(s) available for caffeine and regadenoson
| Article | Year |
|---|---|
Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Caffeine; Coronary Circulation; Cross-Over Studies; Double-Blind Method; Drug Interactions; Heart Rate; Humans; Positron-Emission Tomography; Purines; Pyrazoles; Vasodilator Agents | 2008 |
Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.
Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Adult; Aged; Aged, 80 and over; Caffeine; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Central Nervous System Stimulants; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prevalence; Prospective Studies; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; United States; Young Adult | 2011 |
Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study.
Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Aged, 80 and over; Caffeine; Coronary Disease; Double-Blind Method; Exercise Test; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Prospective Studies; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon | 2014 |
Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
Topics: Administration, Oral; Aged; Aminophylline; Caffeine; Cardiotonic Agents; Causality; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Exercise Test; Female; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Myocardial Perfusion Imaging; New York; Purines; Pyrazoles; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasodilator Agents | 2017 |
Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Caffeine; Cardiovascular Diseases; Coronary Circulation; Dipyridamole; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles | 2019 |
5 other study(ies) available for caffeine and regadenoson
| Article | Year |
|---|---|
Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist.
Topics: Adenosine A2 Receptor Agonists; Animals; Blood Pressure; Caffeine; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Male; Purines; Pyrazoles; Time Factors; Vasodilation | 2007 |
Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson.
Topics: Blood Pressure; Caffeine; Coffee; Female; Habits; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Purines; Pyrazoles; Systole | 2015 |
Intravenous caffeine: An alternative to aminophylline to reverse adverse effects during regadenoson myocardial perfusion imaging.
Topics: Aminophylline; Caffeine; Exercise Test; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents | 2017 |
Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping.
Topics: Adenosine; Aged; Caffeine; Coffee; Coronary Artery Disease; Coronary Circulation; Female; Humans; Hyperemia; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Reproducibility of Results; Time Factors; Vasodilator Agents | 2017 |
Daily Caffeine Consumption Is Associated with Decreased Incidence of Symptoms and Hemodynamic Changes During Pharmacologic Stress with Regadenoson.
Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Aminophylline; Arrhythmias, Cardiac; Blood Pressure; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Eating; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Incidence; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Treatment Outcome | 2020 |